S&P 500 (NYSE:SPY) component Baxter International, Inc. (NYSE:BAX) will unveil its latest earnings on Thursday, July 21, 2011. Baxter International Inc is a company which develops and manufactures healthcare products that save and sustain the lives of people with chronic, acute illnesses. Profitable Companies in the Healthcare Sector to Watch>>
Baxter International, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average estimate of analysts is for profit of $1.02 per share, a rise of 9.7% from the company’s actual earnings for the same quarter a year ago. During the past three months, the average estimate has moved up from $1.01. For the year, analysts are projecting net income of $4.26 per share, a rise of 7% from last year.
Past Earnings Performance: The company has beaten estimates the last four quarters and is coming off a quarter where it topped forecasts by 5 cents, reporting profit of 98 cents per share against a mean estimate of net income of 93 cents per share.
Wall St. Revenue Expectations: On average, analysts predict $3.38 billion in revenue this quarter, a rise of 6% from the year ago quarter. Analysts are forecasting total revenue of $13.66 billion for the year, a rise of 4.6% from last year’s revenue of $13.06 billion.
Analyst Ratings: Analysts are bullish on this stock with 11 analysts rating it as a buy, one rating it as a sell and seven rating it as a hold.
Revenue has risen the past four quarters. Revenue increased 12.2% to $3.28 billion in first quarter. The figure rose 0.8% in the fourth quarter of the last fiscal year from the year earlier, climbed 2.5% in the third quarter of the last fiscal year from the year-ago quarter and 2.3% in the second quarter of the last fiscal year.
Competitors to Watch: Covidien plc (NYSE:COV), C.R. Bard, Inc. (NYSE:BCR), ICU Medical, Incorporated (NASDAQ:ICUI), Teleflex Incorporated (NYSE:TFX), Hospira, Inc. (NYSE:HSP), CryoLife, Inc. (NYSE:CRY), Becton, Dickinson and Co. (NYSE:BDX), CareFusion Corporation (NYSE:CFN), Haemonetics Corporation (NYSE:HAE), and NxStage Medical, Inc. (NASDAQ:NXTM).
Stock Price Performance: During April 19, 2011 to July 15, 2011, the stock price had risen $7.34 (13.7%) from $53.46 to $60.80. The stock price saw one of its best stretches over the last year between October 4, 2010 and October 12, 2010 when shares rose for seven-straight days, rising 3.9% (+$1.81) over that span. It saw one of its worst periods between December 28, 2010 and January 4, 2011 when shares fell for six-straight days, falling 2% (-99 cents) over that span. Shares are up $10.74 (+21.5%) year to date.
(Source: Xignite Financials)
Get Actionable Investing Insights: Check Out Wall St. Cheat Sheet’s newest Feature Trades of the Month!